Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

1 Pharma Stock Poised for a Promising 2023

Following a year of solid growth in 2022, leading pharma company AstraZeneca’s (AZN) robust pipeline and recent launches look promising. Moreover, its strong fundamentals should enable the stock to deliver solid returns this year. So, AZN could be an ideal buy. Keep reading.

StockNews.com

FDA expands contaminated eye product warning due to potential bacterial contamination, risk of blindness

The Food and Drug Administration is adding to a list of eye-care products consumers should stop using “immediately” over concerns of possible bacterial contamination that could lead to blindness if infection occurs.

Tribune News Service

Family of Henrietta Lacks asks court to reject Thermo Fisher’s second motion to dismiss lawsuit

BALTIMORE — Family members of Henrietta Lacks are asking a federal judge to reject Thermo Fisher Scientific’s second attempt to get the court to dismiss the family’s lawsuit against the multimillion-dollar biotech company.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotech Stocks to Buy and Hold for the Next 20 Years

The biotech industry is well-positioned for long-term growth owing to strong demand and continued breakthroughs. Furthermore, favorable government funding should boost the industry’s growth. Hence, it could be wise to buy and hold fundamentally sound biotech stocks Amgen (AMGN), Biogen (BIIB), and Amicus Therapeutics (FOLD) for the next two decades.…

StockNews.com

Fears of new 'zombie drug' which rots users' skin and could even lead to amputations

Animal sedative xylazine started being used on the streets of Puerto Rico but has recently been found in major cities in the US, and causes people's skin to rot off, requiring amputations

Daily Mirror

Is Bristol-Myers a Good Dividend Stock to Pick up Right Now?

Leading pharma company Bristol-Myers Squibb’s (BMY) fiscal year 2022 revenue and EPS were in line with analysts’ estimates. While BMY continues to advance its innovative portfolio and pipeline, is it a good dividend stock to pick up right now? Read more to find out.

StockNews.com

Lateral flow test to detect pregnancy to go on sale in the UK

The SaliStick test kit is thought to be the first of its type in the world

Wales Online

Read news from The Economist, FT, and more,
with one subscription

World's first saliva test to tell if you're pregnant is coming to the UK

The SaliStick test kit was developed by Israeli start-up Salignostics and promises to deliver results in 10 minutes - and is similar to a lateral flow test for coronavirus

Daily Mirror

1 Medical Stock to Buy in February and 1 to Avoid Like the Plague

The medical industry is expected to grow due to increasing healthcare requirements and federal support. Moreover, given the inelastic demand for healthcare products and services, fundamentally strong medical stock Nature's Sunshine Products (NATR) could be an ideal buy this month. However, SNDL (SNDL) might be best avoided, considering its weak…

StockNews.com

4 Pharma Stocks to Buy Now for the Long Haul

The pharma industry has experienced tremendous growth in recent years. The industry should continue to grow, driven by the growing market for personalized medicine and e-pharmacies. Hence, pharma stocks Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and Zoetis (ZTS) might be worth buying for the long term. Also, these companies…

StockNews.com

New door-to-door pharmacy delivery app promises to make London life less painful

It’s like shopping at Boots on your phone with the meds biked to your home in minutes.

Evening Standard

Pharmacy contraceptive pill trial a 'band-aid solution'

The health minister welcomes a proposed trial to allow pharmacists to prescribe the contraceptive pill but doctors' groups have criticised the move.

AAP

The 3 Best Pharma Stocks to Buy for Big Gains in 2023

The pharma industry witnessed solid growth amid the pandemic. Moreover, with surging demand, rising investments in research and development, and increasing e-pharmacy channels, the industry is well-positioned for significant growth over the coming years. Therefore, investors could consider buying fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

StockNews.com

The big business of clogged arteries

Medtronic, the world’s largest medical device company, allegedly "groomed" doctors to overuse its vascular products

Salon

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

StockNews.com

The No. 1 Pharma Stock to Buy for the Long Haul

Despite lingering macro disruptions, Street analysts expect pharma stock Pfizer (PFE) to gain double digits in the near term. Moreover, it pays a reliable dividend. Given its robust fundamentals, I think PFE might be an ideal buy for the long haul. Keep reading.

The Independent UK

FDA panel weighs moving opioid antidote over the counter

U.S. health advisers are weighing whether the overdose-reversal drug naloxone should be made available as an over-the-counter medication

Salon

Prepping for a new post-Roe reality

A decision on a lawsuit in Texas could lead to nationwide mifepristone ban

Get all your
news in one place.

100’s of premium titles.
One news app.

Axios

The administration's next crack at lower drug prices

The Biden administration unveiled three drug payment programs Tuesday aimed at helping reduce patients' out-of-pocket costs.

Insider UK

Edinburgh-based health tech company Clevermed acquired by hospital software specialist System C

Move will support growth of flagship product BadgerNet,

AAP

CSL grows first-half profit 10pct to $2.6 billion

CSL has beaten first-half earnings expectations thanks to its vaccine business and contributions from its new iron deficiency therapy company.

StockNews.com

The Best Stock to Invest $1,000 in Right Now

Pfizer (PFE) played a pivotal role in developing vaccines and pills that helped the world return to normal from the COVID-19 pandemic. The company reported record revenue and earnings in fiscal 2022. Given the company’s solid growth prospects, it could be wise to invest in the stock right now. Keep…

Axios

40 million would lose abortion access if court blocks pill, study shows

163% more women would lose access to abortion care if the FDA's approval of mifepristone is revoked.

The Guardian - UK

Take AstraZeneca’s warning seriously. The UK is missing out in life sciences

Big pharma has choices about where to make new investments and, increasingly it seems, it is not choosing Britain

Chicago Sun-Times

Centene Corp. settles for $215 million on California Medicaid overbilling accusations

More than 20 states are investigating or have investigated Centene’s Medicaid pharmacy billing. The company also has agreed to pay settlements to at least 16 other states, including Illinois and Indiana.

1 … 55 56 57 58

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Medical Pharmaceuticals

125 stories

BIIB

118 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.